Kemp Proteins

Executive Summary

Kemp Proteins is a U.S.-based bioservices company that has been providing end-to-end gene-to-protein solutions to the biotechnology and pharmaceutical industries since 2008. Headquartered in Frederick, Maryland, the company specializes in custom protein expression, antibody development, process development, and analytical characterization. By offering tailored, client-specific project execution, Kemp Proteins supports the drug discovery and development pipeline, helping clients accelerate timelines and ensure quality. The company operates as a private entity without disclosed financials, but its longevity and focus on specialized services position it as a reliable partner in the competitive CRO/CDMO space. With the growing demand for biologics and personalized medicine, Kemp Proteins is well-positioned to capture increased outsourcing from biotech firms seeking high-quality, flexible protein and antibody services. The company's emphasis on client-specific solutions and its experienced team underpin its reputation in the industry.

Upcoming Catalysts (preview)

• Q3 2026Expansion of production capacity or new facility65% success
• Q4 2026Strategic partnership with a large pharma or biotech for antibody development services50% success
• Q2 2026Launch of a novel protein expression platform or technology40% success